Welcome back to another episode of The BioHub, we were thrilled to introduce a guest whose career lies at the cutting edge of cell therapy, biotech leadership, and real-world impact. Abigail Jenkins is a visionary biotech CEO whose journey has taken her from pioneering the development of cell therapies to leading companies at the forefront of regenerative medicine.

Before stepping into her current role, Abigail served as CEO of Gamida Cell, where she guided the company through pivotal stages of clinical development, advanced its pipeline of therapies, and championed innovation in cell-based treatments for patients in need. Her leadership helped bring new hope to people suffering from life-threatening diseases — all while navigating the complexities of regulatory approval, scientific uncertainty, and market pressures.